✦ LIBER ✦

Phase I study of Brequinar sodium (NSC 368390) in patients with solid malignancies

✍ Scribed by Gilberto Schwartsmann; Pierre Dodion; Jan B. Vermorken; Wim W. Bokkel Huinink; Jean Joggi; Benjamin Winograd; Helen Gall; Godeleine Simonetti; Wim J. F. Vijgh; Maike B. Hennik; Nadine Crespeigne; Herbert M. Pinedo

Publisher: Springer
Year: 1990
Tongue: English
Weight: 869 KB
Volume: 25
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00686235

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multicenter phase II study of brequinar

Multicenter phase II study of brequinar sodium in patients with advanced lung cancer

✍ Jean Maroun; John Ruckdeschel; Ronald Natale; Robert Morgan; Brian Dallaire; Reg 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 283 KB

Multicenter phase II study of brequinar

Multicenter phase II study of brequinar sodium in patients with advanced gastrointestinal cancer

✍ Malcolm Moore; Jean Maroun; Francisco Robert; Ronald Natale; James Neidhart; Bri 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 305 KB

Phase I evaluation of ICRF-187 (NSC-1697

Phase I evaluation of ICRF-187 (NSC-169780) in patients with advanced malignancy

✍ Jean Liesmann; Robert Belt; Charles Haas; Barth Hoogstraten 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 366 KB 👁 1 views

Phase I studies of porfiromycin (NSC—564

Phase I studies of porfiromycin (NSC—56410) in solid tumors

✍ Dr. Theodor B. Grage; Arthur J. Weiss; William Wilson; Vernon Reynolds 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 354 KB

Phase I study of paclitaxel poliglumex a

Phase I study of paclitaxel poliglumex administered weekly for patients with advanced solid malignancies

✍ Monica Mita; Alain Mita; John Sarantopoulos; Chris H. Takimoto; Eric K. Rowinsky 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 404 KB

Phase II study of high-dose tamoxifen (N

Phase II study of high-dose tamoxifen (NSC-180973) in patients with disseminated malignant melanoma

✍ Edward T. Creagan; James N. Ingle; David L. Ahmann; Stephanie J. Green 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB 👁 3 views

Seventeen patients with disseminated malignant melanoma received a daily oral regimen of tamoxifen, 100 mg/m2. All patients had prior chemotherapy and predominantly visceral involvement. None of the patients had an objective regression and most (71%) had progressive disease at the time of first reas